Notice Number: NOT-HL-08-123
Key Dates
Release Date: July 3, 2008
Issued by
National Heart, Lung, and Blood Institute (NHLBI), (http://www.nhlbi.nih.gov/)
Purpose
The purpose of this Notice is to correct, clarify and to provide additional information for RFA HL-08-012, NHLBI Progenitor Cell Biology Consortium Planning Awards (R03) http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-08-012.html.
- Correction: Section III.1.A, Eligible Institutions, indicated that “Investigators at foreign sites are permitted to participate in applications originating from US institutions”. This is incorrect; as indicated in the Executive Summary, applications should be submitted from a single domestic institution. For the purposes of this RFA, affiliated institutions (for example, the University of Colorado/National Jewish Medical Center, or the University of Southern California/Children’s Hospital Los Angeles will be considered as single institutions).
- Correction: Section I.1 (Research Objectives) Step 1 indicates that the scope of work proposed in the R03 application should be appropriate for a large R01 application (>$750,000 direct costs per year). This should read ≤$750,000 direct costs per year. The goal of this instruction is to ensure that R03 applications in response to this Funding Opportunity Announcement (FOA) are similar in scale and scope to facilitate review of the proposals.
- Correction: Prospective applicants are asked to submit a letter of intent that includes the following information:
- Descriptive title of proposed research
- Name, address, and telephone number of the Principal Investigator
- Names of other key personnel
- Participating institutions
- Number and title of this funding opportunity
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
The letter of intent is to be sent by July 15, 2008
The letter of intent should be sent to:
Chief, Review Branch
Division of Extramural Affairs
National Heart, Lung, and Blood Institute
Two Rockledge Center, Room 7214
6701 Rockledge Drive
Bethesda, MD 20892-7924 (Express 20817)
Telephone: (301) 435-0270
FAX: (301) 480-0730
Email: [email protected]
- Additional information: A series of Frequently Asked Questions with answers has been posted - http://www.nhlbi.nih.gov/funding/inits/hl-08-012faq.htm
- Clarification: The initial peer review will take place October/November 2008, not necessarily the specific date stated in the FOA.
Inquiries
For information about the consortium mechanism, please contact:
Denis Buxton, Ph.D.
Division of Cardiovascular Diseases
National Heart, Lung, and Blood Institute
Rockledge 2, Room 8216
6701 Rockledge Drive
Bethesda, MD 20892-8902
Telephone: (301) 435-0513
Email: [email protected]
and Human Services (HHS)
